Qure.ai's qXR being used for TB Screening

World Health Organization has introduced the Qure.AI’s artificial intelligence-based tuberculosis diagnostic software as a platform that can replace human specialists in its annual Integrated Tuberculosis Screening Guidelines.

Besides, Mumbai-based Qure.ai, the other two companies are -- Lenit of South Korea and Delft Imaging of the Netherland. The WHO conducted joint research for more than two years with carefully selected global medical AI companies and selected these three companies through internal discussion.

Qure.ai's qXR is an Artificial Intelligence (AI) based chest X-ray interpretation tool that has been trained on millions of chest X-rays. qXR can detect findings suggestive of Tuberculosis (TB) and aids several TB screening programs across the world.

Qure.ai is spread over 35 countries, mostly in Asia, Middle East, Africa, Europe, LatAm, the U.K. and the U.S. In countries like India, Africa, and South-East Asia, its A.I.-assisted medical imaging solutions are already helping small medical teams to turn around lifesaving diagnoses in a fraction of the time normally required.

To prevent tuberculosis, one of the world's highest mortality diseases, the WHO has been publishing guidelines for integrated tuberculosis screenings since 2013.

In this year's guidelines, the WHO recommended a chest X-ray reading test using AI for tuberculosis for the first time, reflecting the research results related to artificial intelligence-based computer-aided diagnosis (CAD).

The updated guidelines said that by using the AI software of companies that took part in the research, it is possible to detect and screen for tuberculosis with more than 90 percent accuracy, a level similar to that of radiologists.

Post a Comment

Previous Post Next Post
Like this content? Sign up for our daily newsletter to get latest updates.